Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein phosphatase 1 regulatory subunit 17 (PPP1R17), also known as G-substrate or GSBS, is a protein primarily expressed in cerebellar Purkinje cells where it functions as an inhibitor of protein phosphatase 1 (PP1) and protein phosphatase 2A (PP2A)[2][7]. It is a substrate for cGMP-dependent protein kinase, and its activity modulates intracellular signal transduction and regulates phosphatase activity—processes important in neural function and development[2][4][7]. Genetic variation in PPP1R17 has been associated with an increased risk of familial hypercholesterolemia and potentially with autism spectrum disorder[2]. There is currently no evidence that it serves as a direct therapeutic target (e.g., for small molecule drugs or biologics), nor is it a well-established biomarker or known to present notable safety concerns in therapeutic contexts.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein phosphatase 1 regulatory subunit 17 (PPP1R17).